Australia's BluGlass secures $6.6M funding boost

Australian semiconductor developer BluGlass (ASX:BLG) has capitalised on its recently expired listed options, bringing in a total of $6.6 million in gross proceeds.

The funding windfall comprises $5.1 million injected directly by option holders exercising their $0.26 options prior to the May 31 expiry, alongside an additional $1.5 million secured via an options shortfall agreement with institutional partner Amery Partners.

Under the shortfall placement, BluGlass will issue 5,769,230 fully paid ordinary shares at $0.26 per share.

In accordance with the original option terms, each shortfall share incorporates a free-attaching, unquoted "piggyback option" exercisable at $0.38 with an expiry date of May 31, 2028, subject to final shareholder approval at the company's upcoming 2026 annual general meeting.

The capital injection strongly complements an upsized $8 million institutional placement completed in April.

Management has confirmed that the combined proceeds will be deployed directly towards supporting working capital requirements and accelerating the commercial scale-up and delivery of its gallium nitride laser contracts.

BluGlass Executive Chair Omer Granit expressed strong confidence in the company's technical trajectory, noting that the high participation rate reflects widespread investor support for its cutting-edge, world-record single-mode laser performance.

Granit emphasised that the recapitalisation uniquely positions the global photonics supplier to advance its manufacturing capabilities and convert growing commercial pipelines across defence, industrial, and biomedical markets globally.